Oxeia Biopharmaceuticals
PrivateLast Round
Crowdfunding
Jan 7, 2026
Est. Valuation
$50M
Total Funding Raised
$1.98M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Oxeia Biopharmaceuticals is a clinical-stage biotechnology company developing OXE103, a therapeutic for the treatment of concussion (mild traumatic brain injury).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oxeia Biopharmaceuticals Comparables
Compare Oxeia Biopharmaceuticals with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Astrocyte Pharmaceuticals Inc. | 83% | |
| Oragenics, Inc. | 78% | |
| Odyssey Health, Inc. | 77% | |
Oxeia Biopharmaceuticals Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Crowdfunding | Jan 7, 2026 | ||||
| Convertible Debt | Nov 18, 2025 | ||||
| Convertible Debt | Oct 2, 2023 | ||||
| Seed | Apr 2, 2015 |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 16, 2026
Monthly visitors increased 82% MoM.
- Nov 9, 2025
Monthly visitors increased 123% MoM, reaching 3.9K.
Oxeia Biopharmaceuticals Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oxeia Biopharmaceuticals's valuation, stock price, and market status.